Long-term niacin treatment induces insulin resistance and adrenergic responsiveness in adipocytes by adaptive downregulation of phosphodiesterase 3B.

The lipid-lowering effect of niacin has been attributed to the inhibition of cAMP production in adipocytes, thereby inhibiting intracellular lipolysis and release of nonesterified fatty acids (NEFA) to the circulation. However, long-term niacin treatment leads to a normalization of plasma NEFA levels and induces insulin resistance, for which the underlying mechanisms are poorly understood. The current study addressed the effects of long-term niacin treatment on insulin-mediated inhibition of adipocyte lipolysis and focused on the regulation of cAMP levels. APOE*3-Leiden.CETP transgenic mice treated with niacin for 15 wk were subjected to an insulin tolerance test and showed whole body insulin resistance. Similarly, adipocytes isolated from niacin-treated mice were insulin resistant and, interestingly, exhibited an increased response to cAMP stimulation by 8Br-cAMP, β1- and β2-adrenergic stimulation. Gene expression analysis of the insulin and β-adrenergic pathways in adipose tissue indicated that all genes were downregulated, including the gene encoding the cAMP-degrading enzyme phosphodiesterase 3B (PDE3B). In line with this, we showed that insulin induced a lower PDE3B response in adipocytes isolated from niacin-treated mice. Inhibiting PDE3B with cilostazol increased lipolytic responsiveness to cAMP stimulation in adipocytes. These data show that long-term niacin treatment leads to a downregulation of PDE3B in adipocytes, which could explain part of the observed insulin resistance and the increased responsiveness to cAMP stimulation.

[1]  D. Rader,et al.  Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression , 2012, Science Translational Medicine.

[2]  S. O’Rahilly,et al.  Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy , 2012, Cardiorenal Medicine.

[3]  S. Heymans,et al.  Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. , 2011, Molecular cell.

[4]  Sangdun Choi,et al.  Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue. , 2011, American journal of physiology. Endocrinology and metabolism.

[5]  Pierre Amarenco,et al.  Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. , 2010, Atherosclerosis.

[6]  B. S. Mohammed,et al.  Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. , 2010, The Journal of clinical endocrinology and metabolism.

[7]  J. Benovic,et al.  Internalization of the Human Nicotinic Acid Receptor GPR109A Is Regulated by Gi, GRK2, and Arrestin3* , 2010, The Journal of Biological Chemistry.

[8]  E. Plaisance,et al.  Extended‐release niacin decreases serum fetuin‐A concentrations in individuals with metabolic syndrome , 2009, Diabetes/metabolism research and reviews.

[9]  J. Jukema,et al.  Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[10]  J. Kotera,et al.  Overview of PDEs and Their Regulation , 2007, Circulation research.

[11]  J. Herman,et al.  Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. , 2006, American journal of physiology. Endocrinology and metabolism.

[12]  J. Jukema,et al.  Cholesteryl Ester Transfer Protein Decreases High-Density Lipoprotein and Severely Aggravates Atherosclerosis in APOE*3-Leiden Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[13]  L. Spriet,et al.  Effects of reduced free fatty acid availability on hormone-sensitive lipase activity in human skeletal muscle during aerobic exercise. , 2004, Journal of applied physiology.

[14]  M. Febbraio,et al.  Reduced plasma FFA availability increases net triacylglycerol degradation, but not GPAT or HSL activity, in human skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.

[15]  C. Holm.  Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. , 2003, Biochemical Society transactions.

[16]  A. O’Sullivan,et al.  Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content. , 2003, Metabolism: clinical and experimental.

[17]  H. Matsushime,et al.  Molecular identification of nicotinic acid receptor. , 2003, Biochemical and biophysical research communications.

[18]  S. Tunaru,et al.  PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect , 2003, Nature Medicine.

[19]  S. Myong,et al.  Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production. , 2001, American journal of physiology. Endocrinology and metabolism.

[20]  Wei Wang,et al.  Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women. , 2000, American journal of physiology. Endocrinology and metabolism.

[21]  G. Boden,et al.  The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. , 1999, The Journal of clinical investigation.

[22]  H. Liu,et al.  Expression of cyclic GMP‐inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: Differential subcellular localization and regulated expression by cyclic AMP , 1998, British journal of pharmacology.

[23]  C. Wernstedt,et al.  Identification of the Site in the cGMP-inhibited Phosphodiesterase Phosphorylated in Adipocytes in Response to Insulin and Isoproterenol (*) , 1996, The Journal of Biological Chemistry.

[24]  H. Quabbe,et al.  Growth hormone, cortisol, and glucagon concentrations during plasma free fatty acid depression: different effects of nicotinic acid and an adenosine derivative (BM 11.189). , 1983, The Journal of clinical endocrinology and metabolism.

[25]  L. Carlson.  INHIBITION OF THE MOBILIZATION OF FREE FATTY ACIDS FROM ADIPOSE TISSUE * , 1965, Annals of the New York Academy of Sciences.

[26]  E. Jacobson,et al.  Niacin: vitamin and antidyslipidemic drug. , 2012, Sub-cellular biochemistry.

[27]  Sangdun Choi,et al.  Widespread effects of nicotinic acid on gene expression in insulin-sensitive tissues: implications for unwanted effects of nicotinic acid treatment. , 2011, Metabolism: clinical and experimental.

[28]  M. Hellerstein,et al.  Erratum: Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women (American Journal of Physiology-Endocrinology and Metabolism (July 2000) 42 (E50-E59)) , 2000 .